Positioning pemetrexed in the treatment of ovarian cancer
- PMID: 19264477
- DOI: 10.1016/j.ejca.2009.02.006
Positioning pemetrexed in the treatment of ovarian cancer
Comment on
-
A randomised, double-blind, phase II study of two doses of pemetrexed in the treatment of platinum-resistant, epithelial ovarian or primary peritoneal cancer.Eur J Cancer. 2009 May;45(8):1415-23. doi: 10.1016/j.ejca.2008.12.013. Epub 2009 Jan 23. Eur J Cancer. 2009. PMID: 19168349 Clinical Trial.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
